Last viewed:
RMTI
Prices are updated after-hours
RMTI
|
$1.47
-3.92%
-4.08%
54K
|
Health Technology
(0.0% 1d)
(-5.6% 1m)
(-30.1% 1y)
(0.0% 2d)
(1.3% 3d)
(3.4% 7d)
(-76.31%
volume)
Earnings Calendar: 2024-03-21
Market Cap: $ 43,165,987
http://www.rockwellmed.com
Sec
Filling
|
Patents
| 299 employees
(United States) Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.
kidney diseases
anemia
iron deficiency
hemodialysis
treatment
kidney
Drugs
Triferic AVNU
(ferric pyrophosphate citrate )
add to watch list
Paper trade
email alert is off
Press-releases
Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda
Published: 2024-04-04
(Crawled : 12:00)
- biospace.com/
RMTI
|
$1.47
-3.92%
-4.08%
54K
|
Health Technology
| -5.56%
| O: 1.23%
H: 6.71%
C: 3.05%
distribution
global
medical
Rockwell Medical Named 'Great Place to Work' for Second Year in a Row
Published: 2024-03-25
(Crawled : 11:00)
- biospace.com/
RMTI
|
$1.47
-3.92%
-4.08%
54K
|
Health Technology
| -10.53%
| O: -1.75%
H: 1.19%
C: -3.57%
year
medical
Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023
Published: 2024-03-21
(Crawled : 12:00)
- biospace.com/
RMTI
|
$1.47
-3.92%
-4.08%
54K
|
Health Technology
| -7.27%
| O: 6.06%
H: 0.57%
C: -13.14%
medical
Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024
Published: 2024-02-08
(Crawled : 12:30)
- biospace.com/
RMTI
|
$1.47
-3.92%
-4.08%
54K
|
Health Technology
| 22.4%
| O: 0.8%
H: 1.59%
C: -2.38%
medical
results
Rockwell Medical to Release Third Quarter 2023 Results on Tuesday, November 14, 2023
Published: 2023-10-16
(Crawled : 12:00)
- biospace.com/
RMTI
|
$1.47
-3.92%
-4.08%
54K
|
Health Technology
| -22.14%
| O: -1.27%
H: 2.06%
C: -3.09%
medical
results
Rockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis Care
Published: 2023-10-03
(Crawled : 12:00)
- biospace.com/
RMTI
|
$1.47
-3.92%
-4.08%
54K
|
Health Technology
| -24.63%
| O: 3.45%
H: 1.9%
C: -1.9%
care
dialysis
medical
agreement
Rockwell Medical Enters into 3-Year Product Purchase Agreement with Sanderling Renal Services; Expands Distribution Capabilities Westward into Utah
Published: 2023-09-28
(Crawled : 11:00)
- biospace.com/
RMTI
|
$1.47
-3.92%
-4.08%
54K
|
Health Technology
| -17.3%
| O: 0.0%
H: 11.35%
C: 8.11%
renal
distribution
medical
agreement
Rockwell Medical Enters into Products Purchase Agreement with its Largest Customer, Enhancing Relationship through 2024
Published: 2023-09-21
(Crawled : 12:30)
- biospace.com/
RMTI
|
$1.47
-3.92%
-4.08%
54K
|
Health Technology
| -19.47%
| O: 0.0%
H: 4.74%
C: 1.05%
medical
agreement
Europe Dialysis Devices Market Analysis Report 2023-2028: Organ Shortage Drives Surge in Dialysis Device Adoption - Portable Solutions Gaining Traction
Published: 2023-08-18
(Crawled : 22:00)
- prnewswire.com
RMTI
|
$1.47
-3.92%
-4.08%
54K
|
Health Technology
| Email alert
Add to watchlist
MDT
|
$80.38
-1.12%
0.0%
5M
|
Health Technology
| Email alert
Add to watchlist
FMCQF
|
$42.034
-0.37%
750
|
Health Services
| Email alert
Add to watchlist
europe
device
report
solutions
dialysis
market
Rockwell Medical Announces Second Quarter 2023 Results
Published: 2023-08-14
(Crawled : 12:00)
- biospace.com/
RMTI
|
$1.47
-3.92%
-4.08%
54K
|
Health Technology
| -48.66%
| O: 3.02%
H: 0.0%
C: -7.17%
medical
results
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount